Theme: “Metabolic Effects of Nicotine: It Matters.”
Training theme is “Research Teams of the Future”
The Diversity-Promoting Institution Drug Abuse Research Program (DIDARP) (R24DA017298) has been funded by the National institute of Drug Abuse (NIDA) since 2004 and was funded for 5 years in 2014. Theodore C. Friedman, MD, PhD is the program director and Vishnudutt Purohit, Ph.D is the NIDA program officer. Our training theme is “Research Teams of the Future.”
The overarching goal of the research, training and education programs of this DIDARP is to enhance CDU’s capacity to conduct substance abuse research with a primary focus on the metabolic effects of nicotine. The specific goals of CDU DIDARP are: To increase the number of high quality drug addiction research projects related to the metabolic effects of nicotine to allow CDU to develop expertise and acquire preliminary data to be able to compete for NIDA P01, P50 or R01 grants; To continue to foster interest in substance abuse research among under-represented students and other trainees by providing meaningful educational and research experiences; and To continue to enhance the research infrastructure at CDU to support substance abuse research.
For more information about drug abuse research at CDU, please contact Dr. Friedman at 310-668-5197 or email@example.com.
Co-Sponsored by UCLA CTSI (Catalyst award), UCLA Integrated Substance Abuse Programs/ Pacific Southwest Addiction Technology Transfer Center, CDU AXIS, and TRDRP.